Literature DB >> 28233206

Mechanical ventilator as a major cause of infection and drug resistance in intensive care unit.

Marwa M E Abd-Elmonsef1, Dalia Elsharawy2, Ayman S Abd-Elsalam3.   

Abstract

Ventilator-associated pneumonia (VAP) is the most frequent infection in intensive care units (ICU). It is associated with high rates of long morbidity and mortality. Management of a case of VAP is often said to add $40,000 to hospital costs USA. All these data directed our interest to study the etiology, risk factors, and antibiotic susceptibility patterns of VAP in ICU of Tanta University Hospital. This study included 36 cases of VAP. Endotracheal aspirates were obtained from all cases and microbiologically analyzed. Samples were collected over 1 year. Forty-two strains were isolated from 28 cases, while eight cases showed no bacterial growth. The most frequent organism was Staphylococcus aureus (30.95%), followed by Acinetobacter baumannii and Pseudomonas aeruginosa (21.43% for each), and the least common was Staphylococcus epidermidis (2.38%). Multi-drug resistance was detected in (50%) of the isolated bacteria in this study. Imipenem, amikacin, linezolid, vancomycin, and levofloxacin are recommended to be the most effective drugs in management of VAP. VAP is a serious problem in ICU carrying many risks for the patient live. Regimens of empirical treatment should take in consideration the update in the bacterial etiology and antibiotic susceptibility patterns of VAP.

Entities:  

Keywords:  Intensive care; Multi-drug resistance; Ventilator-associated pneumonia

Mesh:

Substances:

Year:  2017        PMID: 28233206     DOI: 10.1007/s11356-017-8613-5

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  28 in total

Review 1.  Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996.

Authors:  D E Craven; K A Steger
Journal:  Semin Respir Infect       Date:  1996-03

2.  Ventilator-associated pneumonia in Iranian intensive care units.

Authors:  Aziz Japoni; Afsanah Vazin; Mohammad Ali Davarpanah; Mohammad Afkhami Ardakani; Abdolvahab Alborzi; Sara Japoni; Noradin Rafaatpour
Journal:  J Infect Dev Ctries       Date:  2011-04-26       Impact factor: 0.968

3.  Economic burden of ventilator-associated pneumonia based on total resource utilization.

Authors:  Marcos I Restrepo; Antonio Anzueto; Alejandro C Arroliga; Bekele Afessa; Mark J Atkinson; Ngoc J Ho; Regina Schinner; Ronald L Bracken; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

Review 4.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

5.  Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.

Authors:  Mehri Haeili; Arash Ghodousi; Bijan Nomanpour; Maryam Omrani; Mohammad Mehdi Feizabadi
Journal:  J Infect Dev Ctries       Date:  2013-04-17       Impact factor: 0.968

6.  How to treat VAP due to MDR pathogens in ICU patients.

Authors:  José Garnacho-Montero; Yael Corcia-Palomo; Rosario Amaya-Villar; Luis Martin-Villen
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

7.  A comparative study to assess the effect of amikacin sulfate bladder wash on catheter-associated urinary tract infection in neurosurgical patients.

Authors:  Sumi Zacharias; Srinivas Dwarakanath; Meena Agarwal; Bhavani Shankar Sharma
Journal:  Indian J Crit Care Med       Date:  2009 Jan-Mar

8.  Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit.

Authors:  Bo-Tao Ning; Chen-Mei Zhang; Tao Liu; Sheng Ye; Zi-Hao Yang; Zhen-Jie Chen
Journal:  Exp Ther Med       Date:  2012-10-22       Impact factor: 2.447

9.  Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital.

Authors:  Su Young Chi; Tae Ok Kim; Chan Woo Park; Jin Yeong Yu; Boram Lee; Ho Sung Lee; Yu Il Kim; Sung Chul Lim; Yong Soo Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

10.  Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia.

Authors:  Pieter O Depuydt; Dominique M Vandijck; Maarten A Bekaert; Johan M Decruyenaere; Stijn I Blot; Dirk P Vogelaers; Dominique D Benoit
Journal:  Crit Care       Date:  2008-11-17       Impact factor: 9.097

View more
  2 in total

1.  Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment.

Authors:  Hong-Yan Li; Hai-Shan Wang; Ying-Lin Wang; Jing Wang; Xue-Chen Huo; Quan Zhao
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  Landscape of Multidrug-Resistant Gram-Negative Infections in Egypt: Survey and Literature Review.

Authors:  Amani El-Kholy; Hadir A El-Mahallawy; Noha Elsharnouby; Mohamed Abdel Aziz; Ahmed Mohamed Helmy; Ramy Kotb
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.